Skip to main content

Table 3 Survival and prognosis for hepatoid carcinoma of the pancreas

From: Hepatoid carcinoma of the pancreas

 

Case n

Median (range)

Mean ± SD

1-year survival

5-year survival

P value

Total

22

13.0 (2.0–101.0)

18.1 ± 21.8

71.1 %

40.4 %

 

Location

     

0.780

Pancreatic head

9

8.0 (3.0–48.0)

14.3 ± 14.8

77.8 %

29.2 %

 

Pancreatic body-tail

13

14.0 (2.0–101.0)

20.7 ± 25.9

51.3 %

51.3 %

Histopathology

     

0.763

Pure hepatoid carcinoma

13

12.0 (2.0–48.0)

15.5 ± 13.3

56.1 %

56.1 %

 

Mixed hepatoid carcinoma

8

11.0 (2.8–101.0)

22.7 ± 32.9

75.0 %

25.0 %

Metastasis

     

0.001

No

13

15.0 (4.0–48.0)

18.5 ± 12.3

88.9 %

59.3 %

 

Yes

8

4.5 (2.0–101.0)

18.9 ± 33.8

25.0 %

12.5 %

Lymph node metastasis

     

<0.001

No

15

15.0 (4.0–101.0)

23.7 ± 24.5

83.3 %

62.5 %

 

Yes

4

4.5 (2.0–12.0)

5.8 ± 4.5

0

0

Liver metastasis

     

0.003

No

15

14.0 (4.0–48.0)

17.2 ± 11.9

80.8 %

53.9 %

 

Yes

7

3.0 (2.0–101.0)

20.0 ± 36.4

28.6 %

14.3 %

Resection of tumor

     

<0.001

Yes

17

15.0 (2.0–101.0)

21.8 ± 23.6

53.5 %

53.5 %

 

No

3

6.0 (3.0–12.0)

7.0 ± 4.6

0

0